Table of Contents

Clinical Practice of Molecular Radiotherapy

• You have access

  A Pragmatic Perspective on Molecular Targeted Radionuclide Therapy

  Steven M. Larson and Eric P. Krenning

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 1S-3S;
• You have access

  Radiobiologic Principles in Radionuclide Therapy

  Amin I. Kassis and S. James Adelstein

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 4S-12S;
• You have access

  Combination Radionuclide Therapy Using ¹⁷⁷Lu- and ⁹⁰Y-Labeled Somatostatin Analogs

  Marion de Jong, Wout A.P. Breeman, Roelf Valkema, Bert F. Bernard and Eric P. Krenning

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 13S-17S;
• You have access

  Dosimetry of Internal Emitters

  George Sgouros

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 18S-27S;
• You have access

  The Evolving Role of ¹³¹I for the Treatment of Differentiated Thyroid Carcinoma

  Richard J. Robbins and Martin J. Schlumberger

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 28S-37S;
• You have access

  Bone-Seeking Radionuclides For Therapy

  Val J. Lewington

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 38S-47S;
• You have access

  Radiosynovectomy in Rheumatology, Orthopedics, and Hemophilia

  Peter Schneider, Jamshid Farahati and Christoph Reiners

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 48S-54S;
• You have access

  MIBG and Somatostatin Receptor Analogs in Children: Current Concepts on Diagnostic and Therapeutic Use

  Farzana D. Pashankar, M. Sue O’Dorisio and Yusuf Menda

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 55S-61S;
• You have access

  Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs

  Dik J. Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, Lowell B. Anthony, Stanislas Pauwels, Larry K. Kvols, Thomas M. O’Dorisio, Roelf Valkema, Lisa Bodei, Marco Chinol, Helmut R. Maecke and Eric P. Krenning

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 62S-66S;
• You have access

  Candidates for Peptide Receptor Radiotherapy Today and in the Future

  Jean Claude Reubi, Helmut R. Mäcke and Eric P. Krenning

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 67S-75S;
• You have access

  Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy

  Eric P. Krenning, Roelf Valkema, Dik J. Kwekkeboom, Wouter W. de Herder, Casper H.J. van Eijck, Marion de Jong, Stanislas Pauwels and Jean-Claude Reubi

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 76S-82S;
• You have access

  Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with ⁹⁰Y-DOTA⁰,Tyr³-Octreotide and ¹⁷⁷Lu-DOTA⁰, Tyr³-Octreotate

  Roelf Valkema, Stanislas A. Pauwels, Larry K. Kvols, Dik J. Kwekkeboom, Francois Jamar, Marion de Jong, Raffaella Barone, Stephan Walrand, Peter P.M. Kooij, Willem H. Bakker, Janet Lasher and Eric P. Krenning

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 83S-91S;
• You have access

  Practical Dosimetry of Peptide Receptor Radionuclide Therapy with ⁹⁰Y-Labeled Somatostatin Analogs

  Stanislas Pauwels, Raffaella Barone, Stéphan Walrand, Françoise Borson-Chazot, Roelf Valkema, Larry K. Kvols, Eric P. Krenning and François Jamar

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 92S-98S;
• You have access

  Patient-Specific Dosimetry in Predicting Renal Toxicity with ⁹⁰Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose–Effect Relationship

  Raffaella Barone, Françoise Borson-Chazot, Roelf Valkema, Stéphan Walrand, Franck Chauvin, Lida Gogou, Larry K. Kvols, Eric P. Krenning, François Jamar and Stanislas Pauwels

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 99S-106S;
• You have access

  Peptide Receptor Radionuclide Therapy for Non-Radioiodine-Avid Differentiated Thyroid Carcinoma

  Jaap J.M. Teunissen, Dik J. Kwekkeboom, Peter P.M. Kooij, Willem H. Bakker and Eric P. Krenning

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 107S-114S;
• You have access

  Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies

  Robert M. Sharkey and David M. Goldenberg

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 115S-127S;
• You have access

  Tositumomab and ¹³¹I Therapy in Non-Hodgkin’s Lymphoma

  Richard L. Wahl

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 128S-140S;
• You have access

  Current Status of Therapy of Solid Tumors

  Yuliya S. Jhanwar and Chaitanya Divgi

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 141S-150S;
• You have access

  Current Status of Therapy of Solid Tumors: Brain Tumor Therapy

  Michael R. Zalutsky

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 151S-156S;
• You have access

  Antibody-Based Targeted Radiation to Pediatric Tumors

  Shakeel Modak and Nai-Kong V. Cheung

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 157S-163S;
• You have access

  The Promise of Immuno-PET in Radioimmunotherapy

  Iris Verel, Gerard W.M. Visser and Guus A. van Dongen

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 164S-171S;
• You have access

  ⁶⁸Ga-Labeled Peptides in Tumor Imaging

  Helmut R. Maecke, Michael Hofmann and Uwe Haberkorn

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 172S-178S;
• You have access

  Radiotargeted Gene Therapy

  Donald J. Buchsbaum, Tandra R. Chaudhuri and Kurt R. Zinn

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 179S-186S;
• You have access

  Radiation Sensitizers: A Selective Review of Molecules Targeting DNA and non-DNA Targets

  Larry K. Kvols

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 187S-190S;
• You have access

  Induction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and Peptides

  Leo J. Hofland, Astrid Capello, Eric P. Krenning, Marion de Jong and Martin P. van Hagen

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 191S-198S;
• You have access

  The Promise of Targeted α-Particle Therapy

  Deborah A. Mulford, David A. Scheinberg and Joseph G. Jurcic

  Journal of Nuclear Medicine January 1, 2005, 46 (1 suppl) 199S-204S;